Metformin inhibits the proliferation of canine mammary gland tumor cells through the AMPK/AKT/mTOR signaling pathway in vitro.
Metformin inhibits the proliferation of canine mammary gland tumor cells through the AMPK/AKT/mTOR signaling pathway in vitro.
复制标题
二甲双胍通过AMPK/AKT/mTOR信号通路抑制犬乳腺肿瘤细胞的体外增殖
DOI：
10.3892/ol.2021.13113
复制
发表时间：
2021-12
期刊：
影响因子：
2.9
通讯作者：
Liu Y
中科院分区：
文献类型：
--
作者：
Fan Y;Ren X;Wang Y;Xu E;Wang S;Ge R;Liu Y
作为一种抗糖尿病药物，二甲双胍已被证明具有抗肿瘤作用。然而，减少肿瘤形成（包括犬乳腺肿瘤（CMGT））的机制尚未得到很好的阐明。本研究的目的是评价二甲双胍诱导CMGT细胞凋亡和细胞周期阻滞的能力，以及确定这些作用的潜在途径。用二甲双胍处理后，通过细胞计数试剂盒-8分析评估细胞活力。随后，通过流式细胞术评估细胞凋亡和细胞周期进程，并检测相关蛋白的表达。然后使用蛋白质印迹分析来研究经典AMP活化蛋白激酶（AMPK）、蛋白激酶B（AKT）、雷帕霉素的机械靶标（mTOR）和真核翻译起始因子4 E结合蛋白1（4 E-BP 1）的表达水平。二甲双胍以浓度依赖性方式抑制CHMm细胞的增殖。具体而言，二甲双胍诱导细胞周期停滞在G 0/G1期，伴随p21和p27表达增加，细胞周期蛋白D1和细胞周期蛋白依赖性激酶4表达减少。在CHMm细胞中观察到显著水平的凋亡，同时caspase-3活化和聚（ADP-核糖）聚合酶裂解。Bcl-2表达降低，Bax表达升高。相关信号分子的表达显示，二甲双胍显著增加CHMm细胞中AMPK的磷酸化，并降低磷酸化（p-）AKT、p-mTOR和p-4 E-BP 1的水平，而化合物C逆转了这些变化。这些结果表明，二甲双胍可能是CMGT的潜在治疗药物，通过AMPK/AKT/mTOR信号通路发挥作用。
As an anti-diabetic drug, metformin has been demonstrated to exhibit antitumor effects. However, the mechanisms involved in decreasing tumor formation, including canine mammary gland tumors (CMGTs), are not well elucidated. The aim of the present study was to evaluate the ability of metformin to induce apoptosis and cell cycle arrest in CMGT cells, as well as identifying the pathways underlying these effects. Cell viability was assessed by Cell Counting Kit-8 analysis following treating with metformin. Subsequently, apoptosis and cell cycle progression were assessed by flow cytometry, and the expression of associated proteins was examined. Expression levels of classical AMP-activated protein kinase (AMPK), protein kinase B (AKT), mechanistic target of rapamycin (mTOR) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) were then investigated using western blot analysis. Metformin inhibited the proliferation of CHMm cells in a concentration-dependent manner. Specifically, metformin induced cell cycle arrest in the G0/G1 phases, accompanied by increased expression of p21 and p27, and decreased expression of cyclin D1 and cyclin-dependent kinase 4. Marked levels of apoptosis were observed in CHMm cells alongside the activation of caspase-3 and cleavage of poly(ADP-ribose) polymerase. Also, the level of Bcl-2 was decreased, and that of Bax was increased. The expression of associated signaling molecules revealed that metformin markedly increased the phosphorylation of AMPK in CHMm cells, and decreased the levels of phosphorylated (p-)AKT, p-mTOR and p-4E-BP1, while Compound C reversed these changes. These findings demonstrated that metformin may be a potential therapeutic agent for CMGTs, acting via the AMPK/AKT/mTOR signaling pathway.
登录
查看更多内容
影响因子：
2.6
作者：
Chen YT;Tan KA;Pang LY;Argyle DJ
通讯作者：
Argyle DJ
影响因子：
4.1
作者：
Cho, Sun Wook;Yi, Ka Hee;Park, Do Joon
通讯作者：
Park, Do Joon
DOI：
10.1016/j.bbamcr.2016.12.022
发表时间：
2017-03-01
影响因子：
5.1
作者：
Sergeeva, Tatiana F.;Shirmanova, Marina V.;Zagaynova, Elena V.
通讯作者：
Zagaynova, Elena V.
二甲双胍通过减少 CD133( ) 细胞群并抑制 ERK/P70S6K 信号传导来增加胰腺癌细胞对吉西他滨的敏感性。
影响因子：
4.6
作者：
Chai X;Chu H;Yang X;Meng Y;Shi P;Gou S
通讯作者：
Gou S
影响因子：
9.8
作者：
Lengyel, Ernst;Litchfield, Lacey M.;Mitra, Anirban K.;Nieman, Kristin M.;Mukherjee, Abir;Zhang, Yilin;Johnson, Alyssa;Bradaric, Michael;Lee, WooSeok;Romero, Iris L.
通讯作者：
Romero, Iris L.